Details for New Drug Application (NDA): 216751
✉ Email this page to a colleague
The generic ingredient in MIRTAZAPINE is mirtazapine. There are eighteen drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the mirtazapine profile page.
Summary for 216751
Tradename: | MIRTAZAPINE |
Applicant: | Prasco |
Ingredient: | mirtazapine |
Patents: | 0 |
Suppliers and Packaging for NDA: 216751
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MIRTAZAPINE | mirtazapine | TABLET;ORAL | 216751 | ANDA | Prasco Laboratories | 66993-606 | 66993-606-04 | 500 TABLET, FILM COATED in 1 BOTTLE (66993-606-04) |
MIRTAZAPINE | mirtazapine | TABLET;ORAL | 216751 | ANDA | Prasco Laboratories | 66993-606 | 66993-606-30 | 30 TABLET, FILM COATED in 1 BOTTLE (66993-606-30) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 7.5MG | ||||
Approval Date: | Jan 18, 2023 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 15MG | ||||
Approval Date: | Jan 18, 2023 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 30MG | ||||
Approval Date: | Jan 18, 2023 | TE: | AB | RLD: | No |
Complete Access Available with Subscription